Navigation Links
NFID Announces Recipients of Prestigious 2015 Awards

Bethesda, Maryland (PRWEB) August 07, 2014

The National Foundation for Infectious Diseases (NFID) has selected F. Marc LaForce, MD as recipient of the 2015 Jimmy and Rosalynn Carter Humanitarian Award, Samuel Katz, MD as recipient of the 2015 Maxwell Finland Award for Scientific Achievement, and Richard J. Duma, MD, PhD as recipient of the 2015 John P. Utz Leadership Award.

In recognition of his vision, tenacity, clinical and scientific expertise, and diplomacy in the development and implementation of the group A meningococcal vaccine in Africa, NFID has selected F. Marc LaForce, MD, Director, Technical Services for the Serum Institute of India, Ltd., to receive the 2015 Jimmy and Rosalynn Carter Humanitarian Award. Over a remarkable career, Dr. LaForce has been an outstanding leader in national and global infectious diseases.

“This is a monumental and momentous achievement—one that will continue to benefit humanity in Africa for years going forward: preventing deaths, disease, family anguish, and saving the costs of care,” said William Schaffner, MD, Professor of Preventive Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine and NFID past-president.

Samuel Katz, MD is an innovative physician-scientist whose pioneering work on the development and promotion of the Edmonston measles virus vaccine revolutionized children’s health and reduced childhood mortality worldwide. Dr. Katz successfully introduced measles vaccine to a small village in Nigeria where people were used to their children dying from measles. He has achieved what most investigators dream of: translation of his research into a global resource that has improved public health and the lives of many. In recognition of his contributions, Dr. Katz has been selected to receive the 2015 Maxwell Finland Award for Scientific Achievement.

“Dr. Katz has had a remarkable impact in vaccine research and development and in efforts that have saved lives, decreased human suffering, and reduced healthcare costs in the US and around the world,” said Nancy C. Andrews, MD, PhD, Dean, Duke University School of Medicine. “Dr. Katz is a revolutionary scientist, a respected teacher, a valued colleague, and a tremendous citizen of his profession and the world.”

In recognition of his leadership in the fight against infectious diseases, Richard J. Duma, MD, PhD, has been selected to receive the 2015 John P. Utz Leadership Award. As the founding president of NFID in 1973, Dr. Duma has remained involved and continues to contribute to the mission of NFID through his leadership. The award was established in honor of the late John P. Utz, MD, who was one of NFID’s original founders.

The awards will all be presented at the 2015 NFID Annual Awards Dinner in the spring of 2015 in the Washington, DC area.

About the National Foundation for Infectious Diseases
The National Foundation for Infectious Diseases (NFID) is a non-profit, tax-exempt 501(c)(3) organization founded in 1973 and dedicated to educating the public and healthcare professionals about the causes, treatment, and prevention of infectious diseases across the lifespan. Visit for more information.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards
2. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
3. University of Houston Graduate College of Social Work announces partnership with MD Anderson
4. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
5. AGA announces prestigious awards recognition recipients
6. Announces The Top 3 Heart Rate Monitors
7. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
8. Zane Benefits Announces Wellness HRAs: A New Way to Reward Healthy Employees
9. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
10. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
11. NYC Doc Announces 3 Surprising Ways to Beat Seasonal Allergies
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: